GSK to Sell Legacy Vaccines to Pfizer

June 26, 2015

June 26, 2015.

GlaxoSmithKline has announced that it will sell its meningitis vaccines Nimenrix and Mencevax to Pfizer Ireland Pharmaceuticals. The €115m sale is subject to final European Commission approval, other regulatory approvals, and other customary closing conditions and is expected to close before the end of the year.

Source: GSK

Related Content:

Technology